Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,332 | -12,331 | -6,558 | -21,479 | -16,765 |
| Depreciation Amortization | 427 | 297 | 175 | 783 | 603 |
| Income taxes - deferred | N/A | N/A | N/A | -1,803 | -1,803 |
| Accounts receivable | 339 | 508 | 668 | -446 | -141 |
| Other Working Capital | -5,749 | -2,037 | -939 | -10,804 | -9,577 |
| Other Operating Activity | 3,569 | 2,604 | 871 | 5,183 | 5,136 |
| Operating Cash Flow | $-16,746 | $-10,959 | $-5,783 | $-28,566 | $-22,547 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18 | 18 | N/A | 196 | 196 |
| PPE Investments | -200 | -88 | -38 | -674 | -583 |
| Purchase Of Investment | -8,761 | -8,761 | N/A | -16,403 | -16,403 |
| Sale Of Investment | 4,000 | N/A | N/A | 63,330 | 53,497 |
| Investing Cash Flow | $-4,943 | $-8,831 | $-38 | $46,449 | $36,707 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -40 | -27 | -13 | -54 | -41 |
| Common Stock Issued | 14,186 | 14,176 | 14,057 | 6,514 | 6,713 |
| Common Stock Repurchased | -23 | -23 | -23 | -37 | -37 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -199 |
| Financing Cash Flow | $14,123 | $14,126 | $14,021 | $6,423 | $6,436 |
| Exchange Rate Effect | -120 | -158 | -70 | -250 | -532 |
| Beginning Cash Position | 35,992 | 35,992 | 35,992 | 11,936 | 11,936 |
| End Cash Position | 28,306 | 30,170 | 44,122 | 35,992 | 32,000 |
| Net Cash Flow | $-7,686 | $-5,822 | $8,130 | $24,056 | $20,064 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,746 | -10,959 | -5,783 | -28,566 | -22,547 |
| Capital Expenditure | -200 | -88 | -38 | -674 | -583 |
| Free Cash Flow | -16,946 | -11,047 | -5,821 | -29,240 | -23,130 |